Outsourcing STREAM
-
Meetings That Move Studies Forward
5/6/2026
Explore how fully managed virtual meeting services support clinical research teams with registration, secure portal access, live facilitation, and post-meeting deliverables handled from start to finish.
-
Getting Buy-In For Disclosure As A Service
6/3/2020
Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.
-
Imagine⦠Easier, Proactive Drug Development
2/14/2023
Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.
-
Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments
5/5/2023
Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.
-
Outsourcing Clinical Trial Disclosure Management
6/3/2020
Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.
-
Proactive Drug Development: Explained
1/30/2023
Watch this short video to learn about Proactive Drug Development with Altasciences.
-
A Different Kind Of CRO
1/30/2023
Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.
-
Early Phase Clinical Development Solutions
1/30/2023
Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives.
-
Big Impact With A Personal Touch
1/30/2023
Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.
-
How Sponsors Turn Disclosure As A Service Into A Strategic Advantage
5/18/2020
In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.